APA (7th ed.) Citation

Villiger, P. M., Adler, S., Kuchen, S., Wermelinger, F., Dan, D., Fiege, V., . . . Reichenbach, S. (2016). Tocilizumab for induction and maintenance of remission in giant cell arteritis: A phase 2, randomised, double-blind, placebo-controlled trial. Lancet, 387(10031), 1921. https://doi.org/10.1016/S0140-6736(16)00560-2

Chicago Style (17th ed.) Citation

Villiger, Peter M., Sabine Adler, Stefan Kuchen, Felix Wermelinger, Diana Dan, Veronika Fiege, Lukas Bütikofer, Michael Seitz, and Stephan Reichenbach. "Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-blind, Placebo-controlled Trial." Lancet 387, no. 10031 (2016): 1921. https://doi.org/10.1016/S0140-6736(16)00560-2.

MLA (9th ed.) Citation

Villiger, Peter M., et al. "Tocilizumab for Induction and Maintenance of Remission in Giant Cell Arteritis: A Phase 2, Randomised, Double-blind, Placebo-controlled Trial." Lancet, vol. 387, no. 10031, 2016, p. 1921, https://doi.org/10.1016/S0140-6736(16)00560-2.